Live feed16:05:00·1601dPRReleasevia QuantisnowAngion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surgery-Associated Acute Kidney InjuryByQuantisnow·Wall Street's wire, on your screen.ANGN· Angion Biomedica Corp.Health Care
